Mondrian Investment Partners Ltd Lowers stake in Innospec (IOSP)

Innospec (IOSP) : Mondrian Investment Partners Ltd reduced its stake in Innospec by 8.66% during the most recent quarter end. The investment management company now holds a total of 73,367 shares of Innospec which is valued at $3,942,009 after selling 6,957 shares in Innospec , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Innospec makes up approximately 0.09% of Mondrian Investment Partners Ltd’s portfolio.

Other Hedge Funds, Including , Clark Estates Incny added IOSP to its portfolio by purchasing 52,000 company shares during the most recent quarter which is valued at $2,793,960. Innospec makes up approx 0.52% of Clark Estates Incny’s portfolio.Chicago Equity Partners boosted its stake in IOSP in the latest quarter, The investment management firm added 9,220 additional shares and now holds a total of 51,035 shares of Innospec which is valued at $2,565,529. Innospec makes up approx 0.07% of Chicago Equity Partners’s portfolio.First Citizens Bank Trust Co reduced its stake in IOSP by selling 786 shares or 8.81% in the most recent quarter. The Hedge Fund company now holds 8,139 shares of IOSP which is valued at $409,148. Innospec makes up approx 0.04% of First Citizens Bank Trust Co’s portfolio.Capstone Asset Management Co boosted its stake in IOSP in the latest quarter, The investment management firm added 760 additional shares and now holds a total of 9,510 shares of Innospec which is valued at $467,417. Innospec makes up approx 0.01% of Capstone Asset Management Co’s portfolio.

Innospec opened for trading at $54.46 and hit $58.1999 on the upside on Thursday, eventually ending the session at $57.73, with a gain of 7.44% or 4 points. The heightened volatility saw the trading volume jump to 3,75,616 shares. Company has a market cap of $1,384 M.

On the company’s financial health, Innospec reported $1.03 EPS for the quarter, beating the analyst consensus estimate by $ 0.15 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $0.88. The company had revenue of $228.00 million for the quarter, compared to analysts expectations of $230.30 million. The company’s revenue was down -6.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.02 EPS.

Many Wall Street Analysts have commented on Innospec. Monness Crespi & Hardt Upgraded Innospec on Aug 4, 2016 to ” Buy”, Price Target of the shares are set at $60.

Innospec Inc. develops manufactures blends markets and supplies fuel additives oilfield chemicals personal care and fragrance ingredients and other specialty chemicals. The Company’s products are sold primarily to oil and gas exploration and production companies oil refineries personal care and fragrance companies and other chemical and industrial companies. Its fuel additives improve fuel efficiency boost engine performance and reduce harmful emissions. Its oilfield specialties business supplies drilling and production chemicals for exploration and production. Its other specialty chemicals provide technology-based solutions for its customers’ processes or products focused in the Personal Care Polymers and Fragrance Ingredients markets. Its Octane Additives business manufactures products for use in automotive gasoline and provides services in the environmental remediation. The Company has three business segments: Fuel Specialties Performance Chemicals and Octane Additives.

Leave a Reply

Innospec - Is it time to Sell?

Top Brokerage Firms are advising their investors on Innospec. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.